跳轉至內容
Merck

Gene expression profiling in pachyonychia congenita skin.

Journal of dermatological science (2015-02-07)
Yu-An Cao, Robyn P Hickerson, Brandon L Seegmiller, Dmitry Grapov, Maren M Gross, Marc R Bessette, Brett S Phinney, Manuel A Flores, Tycho J Speaker, Annaleen Vermeulen, Albert A Bravo, Anna L Bruckner, Leonard M Milstone, Mary E Schwartz, Robert H Rice, Roger L Kaspar
摘要

Pachyonychia congenita (PC) is a skin disorder resulting from mutations in keratin (K) proteins including K6a, K6b, K16, and K17. One of the major symptoms is painful plantar keratoderma. The pathogenic sequelae resulting from the keratin mutations remain unclear. To better understand PC pathogenesis. RNA profiling was performed on biopsies taken from PC-involved and uninvolved plantar skin of seven genotyped PC patients (two K6a, one K6b, three K16, and one K17) as well as from control volunteers. Protein profiling was generated from tape-stripping samples. A comparison of PC-involved skin biopsies to adjacent uninvolved plantar skin identified 112 differentially-expressed mRNAs common to patient groups harboring K6 (i.e., both K6a and K6b) and K16 mutations. Among these mRNAs, 25 encode structural proteins including keratins, small proline-rich and late cornified envelope proteins, 20 are related to metabolism and 16 encode proteases, peptidases, and their inhibitors including kallikrein-related peptidases (KLKs), and serine protease inhibitors (SERPINs). mRNAs were also identified to be differentially expressed only in K6 (81) or K16 (141) patient samples. Furthermore, 13 mRNAs were identified that may be involved in pain including nociception and neuropathy. Protein profiling, comparing three K6a plantar tape-stripping samples to non-PC controls, showed changes in the PC corneocytes similar, but not identical, to the mRNA analysis. Many differentially-expressed genes identified in PC-involved skin encode components critical for skin barrier homeostasis including keratinocyte proliferation, differentiation, cornification, and desquamation. The profiling data provide a foundation for unraveling the pathogenesis of PC and identifying targets for developing effective PC therapeutics.

材料
產品編號
品牌
產品描述

Sigma-Aldrich
丙酮, ACS reagent, ≥99.5%
Sigma-Aldrich
丙酮, suitable for HPLC, ≥99.9%
Sigma-Aldrich
丙酮, HPLC Plus, for HPLC, GC, and residue analysis, ≥99.9%
Sigma-Aldrich
丙酮, Laboratory Reagent, ≥99.5%
Sigma-Aldrich
丙酮, puriss. p.a., ACS reagent, reag. ISO, reag. Ph. Eur., ≥99.5% (GC)
Sigma-Aldrich
丙酮, suitable for HPLC, ≥99.8%
Sigma-Aldrich
丙酮, ACS reagent, ≥99.5%
USP
丙酮, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
丙酮, histological grade, ≥99.5%
Sigma-Aldrich
DL-甘油醛-3-磷酸 溶液, 45-55 mg/mL in H2O
Sigma-Aldrich
丙酮, puriss., meets analytical specification of Ph. Eur., BP, NF, ≥99% (GC)
Sigma-Aldrich
丙酮, ≥99%, meets FCC analytical specifications
Sigma-Aldrich
DL-脯氨酸, ReagentPlus®, 99%
Supelco
丙酮, analytical standard
Supelco
丙酮, Pharmaceutical Secondary Standard; Certified Reference Material
脯氨酸, European Pharmacopoeia (EP) Reference Standard